Renk's 7.4 Billion-Euro Order Book Is Real-But the Stock Still Has a Simple Test to Pass

Renk's backlog is real, but investors now want earnings proof

Renk has confirmed that demand is real. The company just posted Q2 order intake of €612.8 million, the strongest quarter on record, lifting the backlog to €7.4 billion. After the backlog story did its job, the market is no longer rewarding the headline by itself. Investors now want proof that those orders can move through the factory and show up in profit.

A backlog is a promise; earnings are the receipt. Renk's defense business already generated €1.02 billion in 2025, which shows the model is working in the real world. But with a €7.4 billion backlog, the key question is no longer demand. It is conversion: how quickly order growth becomes revenue, margin, and cash flow.

Management is already preparing for that handoff by planning roughly €500 million in capacity and development spend. That makes this a capacity-ramp story rather than a pure narrative stock. The main watchpoints are straightforward: can Renk expand output fast enough, and can it clear the export and paperwork bottlenecks that have already slowed some deliveries?

Execution, not demand, is now the real test

The next milestone is simpler and harder than another backlog record: can 2026 guidance turn into 2026 results? After posting Q1 revenue of €273 million, Renk confirmed its full-year 2026 revenue outlook of more than €1.5 billion. That is the real smell test. A story stock can live on promises for a while. An industrial business has to start converting orders into reported numbers.

The product story is concrete

This is not just a generic defense-spending trade. Renk makes transmissions, final drives and suspensions for military tracked and wheeled vehicles, and it says more than seventy armies use its products. That matters because these components are not swapped out lightly. Once a drivetrain or suspension is integrated, the relationship often extends through training, service, and modernization.

The operating proof is already visible

In 2025, Renk delivered revenue of €1.37 billion, adjusted EBIT of €230 million, and a 16.9% adjusted EBIT margin. That matters more than another backlog headline. A full order book does not help if demand never turns into margin. Renk's margin improvement also pointed to increasing operational scaling and strict cost discipline, which is exactly what bulls need to see now.

Delays still matter

The bear case is not about demand. It is about timing. Reuters reported Renk was hampered by order delays and export restrictions, with several naval and R&D programs pushed into 2026. Management argued those programs were shifted, not lost. That may be right, but the same report said the fourth quarter included about €200 million of defense orders moved into 2026, so some of the excitement is timing rather than entirely new demand.

The Israel embargo is another reminder that demand can be real and still wait on approvals. Renk said it could not deliver the requested quantities to Israel because of the export restriction. That is not thesis-breaking, but it is a useful check on any assumption that orders automatically convert one-for-one into revenue on schedule.

What to watch over the next few quarters

• Whether revenue keeps building from the confirmed 2026 guide
• Whether margins hold up as production scales
• Whether delayed programs convert into recognized demand instead of permanent delays
• Whether export clarity improves enough to reduce timing risk

If those boxes keep filling, the backlog starts to look less like a waiting room and more like a pipeline.

The upside may be a post-2028 story, not a one-year sprint

What matters now is not whether Renk has demand. It does. The more important point is the time horizon. This may be less of a one-year squeeze story than a two- to three-year earnings-convergence story.

Management's 2030 targets set the longer arc

Management is now pointing to 2030 revenue of €2.8 billion to €3.2 billion and an adjusted EBIT margin above 20% by 2030. In practical terms, the bigger payoff may arrive after 2028, as backlog finally moves through the factory and into profit. That is actually cleaner than it sounds. If the rerating depends more on earnings power than on endless narrative expansion, investors do not need to guess a 2030 stock price today. They just need to verify that each year delivers another step of proof.

Some optimism is already in the price

That is the difficulty. Renk shares had already risen by more than 50% in the past year before trading around €53.27 and pulling back from a recent high of €56.85. The KNDS block sale of 5.8 million shares also increased free-float supply and added another layer of near-term noise.

So the setup is not clean hype. It is a credible defense-growth story running into a less forgiving market, execution risk, and a payout timeline that may test investor patience.